🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive reviews and detailed guides for preparing or administering at residence.

After minutes of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially significant medical dangers”.